ICU Medical Q4 Revenue Falls 13.8% to $535.9M While EPS Tops by 13.5%
ICU Medical reported Q4 revenue of $535.94 million, down 13.8% year-over-year, exceeding estimates by 1.3%. Adjusted EPS of $1.91 beat consensus by 13.5%, with Infusion Systems at $176.3M, Vital Care at $79.7M and Consumables at $284.7M.
1. Q4 Financial Results
ICU Medical reported Q4 revenue of $535.94 million, down 13.8% year-over-year, exceeding estimates by 1.3%. Adjusted EPS of $1.91 beat consensus by 13.5%, improving from $2.11 a year ago.
2. Segment Performance
The Infusion Systems segment generated $176.3 million versus a $177.6 million estimate, Vital Care delivered $79.7 million ahead of $76.9 million expectations, and Consumables reached $284.7 million above $280.6 million forecasts.
3. Market Reaction and Outlook
Shares have declined 2.3% over the past month, underperforming the broader market, as investors await management’s commentary on guidance and potential estimate revisions for upcoming quarters.